Source – childrenshealthdefense.org
- “…Attempting to lay the psychological groundwork for FDA’s impending authorization, New York Times science writer Apoorva Mandavilli asserted on Oct. 6 that almost 900,000 children had been hospitalized with COVID since the beginning of the pandemic. The Times was forced to retract Mandavilli’s whopper — a 14-fold exaggeration — the next day”
U.S. health officials, with unflagging support from the Biden Administration, are charging full speed ahead on plans to vaccinate children as young as 5 for COVID, despite the extremely low risk the virus poses to kids, and against the urgent warnings of scientists and doctors. According to the Oct. 8 data release from the Vaccine Adverse Event Reporting System (VAERS), more than 21,000 adverse events, including 24 deaths (two of which were suicides), have been reported in the U.S. in 12- to 17-year-olds following experimental COVID shots.
As The Defender reported last week, 21-year-old college student Shawn Kuhn, a senior majoring in exercise and sports science who chose to get fully vaccinated, died on Oct. 11 from “COVID complications.”
Shawn Kuhn, a fully vaccinated senior at the University of Georgia who was majoring in exercise and sports science, died Oct. 11, more than six weeks after developing COVID symptoms.
21-Year-Old Fully Vaccinated Student Dies of COVID, as Breakthrough Cases Continue to ClimbShawn Kuhn, a fully vaccinated senior at the University of Georgia who was majoring in exercise and sports science died Oct. 11, more than six weeks after developing COVID symptoms.
Kuhn’s death raised questions about the potential for fully vaccinated people to develop antibody-dependent enhancement (ADE). Since the vaccines entered clinical trials, scientists have expressed worries about the “ticking time bomb” phenomenon of ADE, which makes vaccinated individuals more, not less, susceptible to severe illness.
Pressure not to report adverse events means that these tragic injuries in young people likely represent a drop in a much deeper bucket. Even assuming a willingness to report reactions, doctors often do not know what an adverse event looks like.
For months, prominent doctors and scientists around the world have issued urgent warnings about the catastrophically bad safety profile of the Pfizer vaccine and other COVID injections, strongly arguing against their use in children.
Several Scandinavian countries paused the use of the Moderna vaccine in younger age groups, concerned with the risk of myocarditis — a move that shamed the U.S. Food and Drug Administration (FDA) into delaying its decision about whether to authorize (on an emergency basis) Moderna’s shot for American 12- to 17-year-olds.
Unfortunately, the FDA and the Centers for Disease Control and Prevention (CDC) are proceeding full steam ahead when it comes to authorizing the Pfizer-BioNTech COVID shot for younger children.
All signs indicate that, by hook or by crook, the agencies that are supposed to protect our children are determined to ignore disproportionate risks and safety signals in order to rush the experimental injections into kids’ arms.
Children’s Health Defense Chairman Robert F. Kennedy, Jr. told thousands who gathered in New York’s Times Square on Oct. 16, “We have no business doing this to little children,” stating that subjecting children to the adverse events of COVID vaccination is unethical and is “medical malpractice.”
A foregone conclusion?
FDA claims it will proceed carefully, “aware of the sensitivities people have about vaccinating children.”
However, the agency’s track record of ignoring or hiding data — and the sunny predictions of former FDA Commissioner and current Pfizer board member Scott Gottlieb — make VRBPAC’s green-lighting of the shots for grade-schoolers practically a foregone conclusion.
In advance of the anticipated FDA authorization, CDC has already issued guidelines on vaccinating children ages 5 to 11, and the Biden administration has purchased 65 million Pfizer pediatric doses — “more than enough to fully vaccinate … all 28 million 5 to 11-year-olds.”
Today, the White House detailed its plan, already in place, to lean on schools and pediatricians to help vaccinate 28 million children.
These actions suggest the CDC’s Advisory Committee on Immunization Practices (ACIP), scheduled to meet Nov. 2 and 3, is poised to rubber-stamp FDA’s decision.
And if ACIP were somehow to fail to play ball, CDC’s rule-by-fiat Director, Dr. Rochelle Walensky, has already shown herself more than capable of overruling her own advisers.
Another round of fear falls flat
Attempting to lay the psychological groundwork for FDA’s impending authorization, New York Times science writer Apoorva Mandavilli asserted on Oct. 6 that almost 900,000 children had been hospitalized with COVID since the beginning of the pandemic.
The Times was forced to retract Mandavilli’s whopper — a 14-fold exaggeration — the next day.
Last May, in studies that a science writer should have been well aware of, California researchers reported that pediatric hospitalizations for COVID were being overcounted by at least 40%, “greatly overestimat[ing] the true burden of COVID-19 disease in children.”
Contrary to Mandavilli’s absurdly inflated claims, pediatric hospitalization numbers for COVID are “vanishingly small.”
Agreeing with this assessment, pediatric specialists at University of California-San Francisco emphasized, “Scientific and media reports that inaccurately portray the risk of COVID-19 to children can do harm by alarming parents.